Autoimmunity in common variable immunodeficiency

  • Shradha Agarwal
  • Charlotte Cunningham-RundlesEmail author


Common variable immunodeficiency (CVID) is the most common clinically significant primary immune defect. Although the hallmark of CVID is hypogammaglobulinemia, the intrinsic dysregulation of the immune system leads to defective T-cell activation and proliferation, as well as dendritic cell and cytokine defects. Although 70% to 80% of patients have had recurrent sinopulmonary infections, autoimmunity and inflammatory complications are also common. The most common autoimmune conditions are immune thrombocytopenic purpura and hemolytic anemia, but other autoimmune complications arise, including rheumatoid arthritis, pernicious anemia, primary biliary cirrhosis, thyroiditis, sicca syndrome, systemic lupus, and inflammatory bowel disease. Treatment of autoimmunity includes highdose immunoglobulins, corticosteroids, selected immu no suppressants, and other immune modulators. This review focuses on autoimmune conditions associated with CVID, potential mechanisms of immune dysregulation, and therapeutic strategies.


Systemic Lupus Erythematosus Primary Biliary Cirrhosis Allergy Clin Immunol Pernicious Anemia Immune Thrombocytopenic Purpura 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Geha RS, Notarangelo LD, Casanova JL, et al.: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776–794.PubMedCrossRefGoogle Scholar
  2. 2.
    Chapel H, Lucas M, Lee M, et al.: Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008, 112:277–286.PubMedCrossRefGoogle Scholar
  3. 3.
    Cunningham-Rundles C: Common variable immunodeficiency. Curr Allergy Asthma Rep 2001, 1:421–429.PubMedCrossRefGoogle Scholar
  4. 4.
    Quinti I, Soresina A, Spadaro G, et al.: Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007, 27:308–316.PubMedCrossRefGoogle Scholar
  5. 5.
    Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34–48.PubMedCrossRefGoogle Scholar
  6. 6.
    Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005, 25:57–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Michel M, Chanet V, Galicier L, et al.: Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004, 83:254–263.CrossRefGoogle Scholar
  8. 8.
    Swierkot J, Lewandowicz-Uszynska A, Chelbicki A, et al.: Rheumatoid arthritis in a patient with common variable immunodeficiency: difficulty in diagnosis and therapy. Clin Rheumatol 2006, 25:92–94.PubMedCrossRefGoogle Scholar
  9. 9.
    Bloom KA, Chung D, Cunningham-Rundles C: Osteoarticular infectious complications in patients with primary immunodeficiencies. Curr Opin Rheumatol 2008, 20:480–485.PubMedCrossRefGoogle Scholar
  10. 10.
    Fernandez-Castro M, Mellor-Pita S, Citores MJ, et al.: Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum 2007, 36:238–245.PubMedCrossRefGoogle Scholar
  11. 11.
    Yong PF, Aslam L, Karim MY, et al.: Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:1400–1405.CrossRefGoogle Scholar
  12. 12.
    Mechanic LJ, Dikman S, Cunningham-Rundles C: Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997, 127:613–617.PubMedGoogle Scholar
  13. 13.
    Morimoto Y, Routes JM: Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 2005, 5:370–375.PubMedCrossRefGoogle Scholar
  14. 14.
    Mullighan CG, Fanning GC, Chapel HM, et al.: TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997, 159:6236–6241.PubMedGoogle Scholar
  15. 15.
    Aukrust P, Lien E, Kristoffersen AK, et al.: Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences. Blood 1996, 87:674–681.PubMedGoogle Scholar
  16. 16.
    Kalia S, Dutz JP: New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007, 20:160–174.PubMedCrossRefGoogle Scholar
  17. 17.
    Daniels JA, Lederman HM, Maitra A, et al.: Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007, 31:1800–1812.PubMedCrossRefGoogle Scholar
  18. 18.
    Daniels JA, Torbenson M, Vivekanandan P, et al.: Hepatitis in common variable immunodeficiency. Hum Pathol 2009, 40:484–488.PubMedCrossRefGoogle Scholar
  19. 19.
    Bryant A, Calver NC, Toubi E, et al.: Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 1990, 56:239–248.PubMedCrossRefGoogle Scholar
  20. 20.
    Cunningham-Rundles C, Radigan L, Knight AK, et al.: TLR9 activation is defective in common variable immune deficiency. J Immunol 2006, 176:1978–1987.PubMedGoogle Scholar
  21. 21.
    Eisenstein EM, Chua K, Strober W, et al.: B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol 1994, 152:5957–5968.PubMedGoogle Scholar
  22. 22.
    Bonhomme D, Hammarstrom L, Webster D, et al.: Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 2000, 165:4725–4730.PubMedGoogle Scholar
  23. 23.
    Warnatz K, Denz A, Drager R, et al.: Severe deficiency of switched memory B cells (CD27(+)IgM(−)IgD(−)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544–1551.PubMedCrossRefGoogle Scholar
  24. 24.
    Wehr C, Kivioja T, Schmitt C, et al.: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77–85.PubMedCrossRefGoogle Scholar
  25. 25.
    Alachkar H, Taubenheim N, Haeney MR, et al.: Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 2006, 120:310–318.PubMedCrossRefGoogle Scholar
  26. 26.
    Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 2005, 116:37–41.PubMedCrossRefGoogle Scholar
  27. 27.
    Sanchez-Ramon S., Radigan L, Yu JE, et al.: Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 2008, 128:314–321.PubMedCrossRefGoogle Scholar
  28. 28.
    Mackay F, Silveira PA, Brink R: B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 2007, 19:327–336.PubMedCrossRefGoogle Scholar
  29. 29.
    Knight AK, Radigan L, Marron T, et al.: High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol 2007, 124:182–189.PubMedCrossRefGoogle Scholar
  30. 30.
    Genre J, Errante PR, Kokron CM, et al.: Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with common variable immunodeficiency: a link to autoimmunity? Clin Immunol 2009 Apr 23 (Epub ahead of print).Google Scholar
  31. 31.
    Yu GP, Chiang D, Song SJ, et al.: Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 2009, 131:240–253.PubMedCrossRefGoogle Scholar
  32. 32.
    Vorechovsky I, Zetterquist H, Paganelli R, et al.: Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995, 77:185–192.PubMedCrossRefGoogle Scholar
  33. 33.
    Schaffer AA, Salzer U, Hammarstrom L, et al.: Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007, 17:201–212.PubMedCrossRefGoogle Scholar
  34. 34.
    Sekine H, Ferreira RC, Pan-Hammarstrom Q, et al.: Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 2007, 104:7193–7198.PubMedCrossRefGoogle Scholar
  35. 35.
    Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261–268.PubMedCrossRefGoogle Scholar
  36. 36.
    van Zelm MC, Reisli I, van der Burg M, et al.: An antibodydeficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901–1912.PubMedCrossRefGoogle Scholar
  37. 37.
    Goldacker S, Warnatz K: Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005, 5:504–509.PubMedCrossRefGoogle Scholar
  38. 38.
    Castigli E, Wilson SA, Garibyan L, et al.: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829–834.PubMedCrossRefGoogle Scholar
  39. 39.
    Salzer U, Chapel HM, Webster AD, et al.: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820–828.PubMedCrossRefGoogle Scholar
  40. 40.
    Pan-Hammarstrom Q, Salzer U, Du L, et al.: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39:429–430.PubMedCrossRefGoogle Scholar
  41. 41.
    Zhang L, Radigan L, Salzer U, et al.: Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007, 120:1178–1185.PubMedCrossRefGoogle Scholar
  42. 42.
    Salzer U, Bacchelli C, Buckridge S, et al.: Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113:1967–1976.PubMedCrossRefGoogle Scholar
  43. 43.
    Warnatz K, Wehr C, Drager R, et al.: Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 2002, 206:502–513.PubMedCrossRefGoogle Scholar
  44. 44.
    Yong PF, Workman S, Wahid F, et al.: Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol 2008, 127:34–42.PubMedCrossRefGoogle Scholar
  45. 45.
    Giovannetti A, Pierdominici M, Mazzetta F, et al.: Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178:3932–3943.PubMedGoogle Scholar
  46. 46.
    Cunningham-Rundles C, Radigan L: Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 2005, 115:147–153.PubMedCrossRefGoogle Scholar
  47. 47.
    Sneller MC: Common variable immunodeficiency. Am J Med Sci 2001, 321:42–48.PubMedCrossRefGoogle Scholar
  48. 48.
    Holm AM, Aukrust P, Damas JK, et al.: Abnormal interleukin-7 function in common variable immunodeficiency. Blood 2005, 105:2887–2890.PubMedCrossRefGoogle Scholar
  49. 49.
    Rezaei N, Amirzagar AA, Shakiba Y, et al.: Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009, 155:21–27.PubMedCrossRefGoogle Scholar
  50. 50.
    Eisenstein EM, Jaffe JS, Strober W: Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Immunol 1993, 13:247–258.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Mount Sinai Medical CenterNew YorkUSA

Personalised recommendations